Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Pfizer has announced its $4.9 billion acquisition of biotech firm Metsera, adding advanced GLP-1 and amylin-based obesity treatments to its pipeline
Semaglutide slows gastric emptying, allowing food to remain in the stomach longer so satiety signals persist
The injection is quick and uses a small needle
Body weight dropped by an average of 24.2% at 48 weeks in the highest-dose group, versus 2.1% on placebo
Kaisers 2026 formulary includes six GLP-1 medications: Wegovy (semaglutide for obesity and CVD), Zepbound (tirzepatide for obesity and OSA), Ozempic (semaglutide for type 2 diabetes), Mounjaro (tirzepatide for type 2 diabetes), Saxenda (liraglutide for obesity), and Rybelsus (oral semaglutide for type 2 diabetes)
Why people confuse Toujeo with GLP-1 medications The confusion between Toujeo and GLP-1 drugs is not random
US$ 21.02
US$ 21.52
US$ 26.16
US$ 28.29
US$ 29.15
US$ 21.77
US$ 27.77
US$ 22.76
US$ 24.22
